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ATP-binding cassette (ABC) superfamily members have a key role as nutrient importers
and exporters in bacteria. However, their role as drug exporters in eukaryotes brought
this superfamily member to even greater prominence. The capacity of ABC transporters
to efflux a broad spectrum of xenobiotics represents one of the major mechanisms of
clinical multidrug resistance in pathogenic fungi including Candida species. Candida
auris, a newly emerged multidrug-resistant fungal pathogen of humans, has been
responsible for multiple outbreaks of drug-resistant infections in hospitals around the
globe. Our study has analyzed the entire complement of ABC superfamily transporters
to assess whether these play a major role in drug resistance mechanisms of C. auris.
Our bioinformatics analyses identified 28 putative ABC proteins encoded in the genome
of the C. auris type-strain CBS 10913T; 20 of which contain transmembrane domains
(TMDs). Quantitative real-time PCR confirmed the expression of all 20 TMD transporters,
underlining their potential in contributing to the C. auris drug-resistant phenotype.
Changes in transcript levels after short-term exposure of drugs and in drug-resistant
C. auris isolates suggested their importance in the drug resistance phenotype of this
pathogen. CAUR_02725 orthologous to CDR1, a major multidrug exporter in other
yeasts, showed consistently higher expression in multidrug-resistant strains of C. auris.
Homologs of other ABC transporter genes, such as CDR4, CDR6, and SNQ2, also
displayed raised expression in a sub-set of clinical isolates. Together, our analysis
supports the involvement of these transporters in multidrug resistance in C. auris.
Keywords: Candida auris, multidrug resistance, ABC proteins, drug efflux pumps, fluconazole
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INTRODUCTION
The ATP-binding cassette (ABC) proteins are one of the
largest superfamily of proteins found in both prokaryotes
and higher eukaryotes. The eukaryotic ABC transporters are
promiscuous exporters and can extrude a variety of substrates
including metals, drugs, xenobiotics, lipids, and other cellular
metabolites (Prasad and Goffeau, 2012). A large number of
ABC proteins are multidrug transporters and function as eﬄux
pumps. Rapid active drug extrusion from cells represents one
of the major mechanisms of multidrug resistance, frequently
encountered in organisms ranging from bacteria to mammals
(Prasad and Goffeau, 2012). However, the function of ABC
proteins is not limited to detoxification or drug expulsion,
since many of its members perform diverse cellular functions.
Among others, these include roles in vacuole fusion, maintaining
mitochondrial integrity, lipid translocation, and pheromone
secretion (Khandelwal et al., 2016; Prasad et al., 2016). Notably,
the ABC proteins play major roles in various human diseases,
such as cystic fibrosis, Tangier’s disease, adrenoleukodystrophy,
and cancer (Dean et al., 2001b).
Candida species are the fourth most common cause of fungal
blood stream infections, and among them Candida albicans is
the most prevalent agent of superficial and systemic disease
(Wisplinghoff et al., 2004; Tortorano et al., 2006). However,
recent global emergence of multidrug-resistant Candida auris
has become a major health concern (Cortegiani et al., 2018).
Compared to other pathogenic Candida species, C. auris
has unique features, which make it difficult to treat and
eradicate from intensive care hospital wards (Forsberg et al.,
2019). This fungus is mostly associated with clonal outbreaks
that spread rapidly through health care facilities. C. auris is
frequently resistant to commonly used frontline antifungals
of different classes. An initial study on C. auris showed
that it is phylogenetically related to Candida haemulonii and
has the largest numbers of orthologs with Candida lusitaniae
(Chatterjee et al., 2015).
Whole-genome sequence (WGS) analyses of C. auris isolates
from different countries led to a subdivision into four distinct
clades specific to a geographic area, thus indicating the
simultaneous emergence of C. auris in different continents
(Lockhart et al., 2017). Based on the geographically restricted
area of isolation, the authors have classified the clades as follows:
clade I comprises isolates from India and Pakistan, clade II
from Japan and South Korea, clade III from South Africa,
and clade IV from Venezuela (Schelenz et al., 2016; Lockhart
et al., 2017; Muñoz et al., 2018; Rhodes et al., 2018). As per
this classification, the C. auris strain, CBS 10913T belongs to
clade II (Japan and South Korea) and the three Indian clinical-
resistant isolates used in this study probably belong to clade I
(India and Pakistan). The different clades are differentiated by
thousands of single-nucleotide polymorphisms (SNPs), whereas
genetic differences within each geographic clade are minimal
(Lockhart et al., 2017). Importantly, not much is known
about phenotypic differences between isolates from different
C. auris clades. Initial WGS of a C. auris isolate has revealed
that approximately 2.4% of its genes encode ABC and major
facilitator superfamily (MFS) transporters along with other
transporters like oligopeptide transporters and iron transporters,
etc. (Chatterjee et al., 2015). Two recent simultaneously published
reports confirmed the role of ABC transporter CDR1 and
MFS transporter MDR1 in azole resistance (Kim et al., 2019;
Rybak et al., 2019).
Our study presents the identification and expression
analysis of ABC proteins on a genome-wide scale in the
pathogenic yeast C. auris. For this, we performed WGS of
the C. auris type-strain, CBS 10913T (clade II – Japan and
South Korea), recovered in 2009 from a Japanese patient with an
ear infection (Satoh et al., 2009). Our bioinformatics analysis of
the genome of CBS 10913T identified 28 putative ABC proteins.
Based on phylogenetic analysis, domain organization, and
following the nomenclature adopted by the Human Genome
Organization (HUGO) scheme (Vasiliou et al., 2009), these
proteins are classified into six subfamilies ABCB/MDR,
ABCC/multidrug resistance-associated protein (MRP),
ABCD/ALDp, ABCE/RLI, ABCF/YEF3, and ABCG/PDR.
Among these, 20 contained transmembrane domains (TMDs).
The TMD ABC transporters predominantly belong to the
ABCG/PDR, ABCB/MDR, ABCC/MRP, and ABCD/ALDp
subfamilies. Comparative phylogenetic analysis of the ABC
proteins with C. albicans, Saccharomyces cerevisiae, and
Debaryomyces hansenii revealed orthologous relationships and
highlighted their conservation. We also demonstrate that the
expression of various ABC transporters changes substantially
in the presence of different antifungal drugs suggesting a
potential role in drug resistance in C. auris. The comparative
expression landscape of all transcripts of ABC transporters
in the clade I multidrug-resistant hospital isolates of C. auris
suggests a possible role of selected ABC proteins in conferring
drug resistance.
MATERIALS AND METHODS
Yeast Strains, Culture Conditions, and
Antifungal Drugs
The C. auris type strain CBS 10913T was obtained from the
CBS-KNAW fungal culture collection of the Westerdijk Fungal
Biodiversity Institute, Utrecht, Netherlands. Although B11220
and CBS 10913T have apparently been isolated from the same
original material they seem not to be completely identical.
Additionally, their karyotypes are overall quite similar, but show
some differences (Bravo Ruiz et al., 2019).
Three drug-resistant clinical isolates (Isolate 1-NCCPF470150,
Isolate 2-NCCPF 470156, and Isolate 3-NCCPF470114) of
C. auris were provided by the National Culture Collection of
Fungal Pathogens, Postgraduate Institute of Medical Education
& Research, Chandigarh, India. All yeast strains used in this
study are listed in Supplementary Table S1. Yeasts were
grown on yeast extract/peptone/dextrose (YEPD; Difco,
Sparks, MD, United States). The antifungals amphotericin
B (AMPB), terbinafine (TRB), and fluconazole (FLU)
were procured from the Sigma Chemical Co. (St. Louis,
MO, United States).
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Whole-Genome Sequencing (WGS) and
Assembly
Genomic DNA of strain CBS 10913T was extracted from an
overnight culture in YEPD broth using an established protocol.
Briefly, cells were resuspended in equal volumes of extraction
buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris
pH 8.0, 1mM EDTA) and phenol:chloroform:isoamyl alcohol
(25:24:1). Vigorous shaking in the presence of acid-washed glass
beads was applied to break the cell wall. After addition of a
volume of 1× Tris–EDTA (TE pH 7.5) and centrifugation (5 min,
14,000 × g), the aqueous layer was mixed with 2.5 volumes of
100% ethanol to precipitate the DNA. Following centrifugation
(2 min, 14,000 × g) the pelleted genomic DNA was suspended
in 1 volume of 1× TE containing 250 µg/ml RNase A and
incubated for 20 min at 37◦C. DNA was then precipitated by
adding 1/20 of a volume of 3 M sodium acetate and 2.5 volumes
of 100% ethanol followed by centrifugation (10 min, 14,000× g),
finally DNA was resuspended in sterile water. Concentration
and purity of the DNA preparation were determined on a
NanoDropTM Spectrophotometer (Thermo Fisher Scientific,
Waltham, MA, United States). A genomic library was prepared
and barcoded at the Centre of Genome-Enabled Biology and
Medicine (CGEBM, University of Aberdeen) using the Nextera
DNA Library Preparation Kit (Illumina, Inc., San Diego, CA,
United States), and WGS was performed on an Illumina MiSeq
sequencer at CGEBM. Sequence reads were subjected to quality
control inspection and trimming using FASTX-toolkit1 and
FastQC2, and adaptor sequences were removed using Cutadapt
(Martin, 2011). Velvet (Zerbino, 2010) and ABySS (Simpson
et al., 2009) assemblers were used in standard and optimized
mode with three sets of paired end reads: untrimmed reads, reads
trimmed to a base quality score of 36, and to a base quality
score of 28. CEGMA was used to conduct assembly quality
control checks for genome completeness (Parra et al., 2007).
The initial assembly was scaffolded using read alignments with
BESST (Sahlin et al., 2014) and extended using IMAGE in PAGIT.
The contiguity of the assembly was then improved by additional
scaffolding against the published genome of the closely related
species C. lusitaniae using Newbler aligner. Resulting contigs
were curated to retain only contigs with read coverage >100 and
<10,000 and a length of >1,000 bp, gap closing was performed
using SSPACE-LongRead (Boetzer and Pirovano, 2014). The raw
sequence files are available at https://www.ebi.ac.uk/ena/data/
view/PRJEB29190 (ENA Accession No. PRJEB29190).
Identification of ABC Proteins
A total of 5,279 proteins were identified in the genome of C. auris
CBS 10913T. The HMM profile of the ABC-tran model (accession
PF00005) obtained from the Pfam database3 was used as query
against the proteins of C. auris in the HMM search program of
HMMER package4 with default parameters (Finn et al., 2016). For
further filtering of hits obtained after HMM search cut-off was
1http://hannonlab.cshl.edu/fastx_toolkit/links.html
2https://www.bioinformatics.babraham.ac.uk/projects/fastqc/
3http://pfam.sanger.ac.uk/
4http://hmmer.org/
decided on the basis of plots between domain scores and E-values.
Domain (bit) scores above 69.4 and E-values below 1.3e−19
were considered positive for having an NBD domain. Sequences
thus selected were taken forward as putative ABC proteins for
detailed analysis.
Retrieving of Sequences and
Phylogenetic Analysis
For combined phylogenetic analysis S. cerevisiae, C. albicans,
and D. hansenii sequences were retrieved from UniProt using
previously published information (Wasi et al., 2018), and aligned
with C. auris sequences by Clustal using default parameters.
The phylogenetic tree was constructed by MEGA 6.06 (Tamura
et al., 2013) using the neighbor-joining method (Wasi et al., 2018)
for the clustering, and the Poisson substitution for calculating the
evolutionary distance. 1,000 bootstrap replicates were utilized to
establish the tree topology. To calculate the sequence identities
of ABC proteins among different species the web-based BLASTp
program from NCBI5 was used.
Subcellular Localization Prediction
To predict the subcellular localization of ABC transporters, we
used WoLF PSORT6 and DEEPLOC7 software.
RNA Isolation, cDNA Synthesis, and
Quantitative Real-Time PCR
For the total RNA isolation, a primary culture was grown
overnight to saturation. From this a secondary culture was
inoculated in YEPD broth at an OD600 of 0.2, and grown
for 6 h. The cultures were incubated for another 60 min
with the indicated concentrations of drugs (Supplementary
Table S2), and then collected by centrifugation, and washed
with DEPC-treated water. Total RNA was isolated using an
RNeasy Mini Kit (Qiagen, Hilden, Germany), following the
manufacturer’s specifications. cDNA synthesis was performed
using the RevertAid H Minus First Strand cDNA Synthesis
Kit (Thermo Fisher Scientific, Waltham, MA, United States)
according to the manufacturer’s instruction. iTaq Universal SYBR
green super mix Bio-Rad was used along with the desired gene-
specific oligonucleotide primers (Supplementary Table S3) to
evaluate the quantitative expression profile.
TDH1 (CAUR_02457), an ortholog of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as an internal
control for normalization of expression. For the constitutive
expression profile the 1CT of TDH1 was subtracted from
the specific gene. The relative expression profiles under drug
stresses were calculated using the 2−11CT method (Livak
and Schmittgen, 2001) in comparison to untreated cells.
The experiments were performed in biological duplicates
and technical triplicates. Statistical significance values were
calculated using a two-way ANOVA (uncorrected Fisher’s LSD)
in GraphPad Prism 6 software.
5https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins
6https://wolfpsort.hgc.jp/
7http://www.cbs.dtu.dk/services/DeepLoc/
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MIC50 Determination
Antifungal susceptibility testing was performed according to
the broth micro-dilution technique guidelines of the Clinical
and Laboratory Standards Institute (CLSI) for AMPB, FLU,
voriconazole (VRC), and itraconazole (ITR) (Clinical and
Laboratory Standards Institute, 2008). Due to clinical breakpoints
not being available for C. auris, the interpretation of the
breakpoints suggested for yeast was followed. For AMPB, an
MIC50 of 1 mg/l was considered resistant. Candida krusei (ATCC
6258) and Candida parapsilosis (ATCC 22019) were used as
control organisms (Supplementary Table S1).
RESULTS AND DISCUSSION
Ploidy Determination and Genome-Wide
Sequencing of C. auris
A WGS (close to 200× coverage) of the type strain of C. auris,
CBS 10913T belonging to the E. Asian geographical clade
(Lockhart et al., 2017) was generated using an Illumina MiSeq
sequencer (ENA Accession No. PRJEB29190). Final assembly
produced a 12.1 Mb genome distributed over 71 contigs with
an N50 of 379.6 kb and a GC content of 45%. A total of 5,279
open-reading frames (ORFs) have been identified in the genome
of CBS 10913T, which is comparable to published WGSs of other
C. auris isolates (Muñoz et al., 2018; Rhodes et al., 2018). The
genome ploidy of C. auris CBS 10913T was confirmed as being
haploid using flow cytometry by comparison to a bona fide
haploid S. cerevisiae strain BY4741 (Supplementary Figure S1).
The resulting assembly size of 12.1 Mb and the flow cytometric
analysis are in line with previously reported haploid genome sizes
of C. auris (Lockhart et al., 2017; Muñoz et al., 2018; Rhodes et al.,
2018; Bravo Ruiz et al., 2019).
Identification of Putative ABC Proteins of
C. auris
To identify the ABC proteins in C. auris CBS 10913T, we used
the hidden Markov models (HMMs) profile of ATP-binding
domain alignment Pfam (00005) as a query against the 5,279
protein sequences extracted from the C. auris CBS 10913T
WGS. The initial screening of the HMM profile resulted in 51
sequences as proteins of interest (Supplementary Table S4).
After applying cut-off values of 69.4 for the bit scores and 1.3e−19
for the E-values, 28 sequences were identified as significant
matches and were subjected to further analysis (Table 1 and
Supplementary Figure S2). These 28 sequences were confirmed
to contain the ABC-specific nucleotide-binding domain (NBD)
by ScanProsite8 (Table 1).
To be classified as an ABC transporter protein, at least one
NBD and one TMD must be present in the protein sequence.
ABC proteins which lack TMDs are considered as soluble ABC
proteins (Prasad et al., 2015). To predict the TMDs among all
the putative ABC proteins, we used TOPOCONS and TMPred
software, which led to the identification of 20 proteins, which
8http://prosite.expasy.org/scanprosite/
TABLE 1 | List of ABC proteins identified in C. auris and their molecular size
features.
Protein name Number of
amino acids
Size in kDa Subfamily Orthologs in
C. albicans
CAUR_02725 1,508 169.9196 PDR/ABCG CDR1
CAUR_01285 1,452 163.474 PDR/ABCG SNQ2
CAUR_01276 1,486 166.899 PDR/ABCG SNQ2
CAUR_05555 1,441 163.6461 PDR/ABCG CDR4
CAUR_02773 1,469 166.9447 PDR/ABCG CDR4
CAUR_04233 1,264 141.1817 PDR/ABCG CDR6(ROA1)
CAUR_03774 1,012 113.6363 PDR/ABCG ADP1
CAUR_01852 1,907 213.6577 MDR/ABCB HST6
CAUR_03761 679 75.3979 MDR/ABCB MDL1
CAUR_04565 1,432 160.1326 MDR/ABCB MDL2
CAUR_02994 703 78.3624 MDR/ABCB ATM1
CAUR_01188 1,659 185.6801 MRP/ABCC YBT1
CAUR_00156 1,469 165.7274 MRP/ABCC YCF1
CAUR_00964 1,604 180.0822 MRP/ABCC MLT1
CAUR_01719 1,560 176.1635 MRP/ABCC YOR1
CAUR_00368 1,424 160.218 MRP/ABCC YOR1
CAUR_03320 1,566 175.1847 MRP/ABCC YCF1
CAUR_02951 1,406 158.184 MRP/ABCC YOR1
CAUR_00862 758 85.9342 ALDP/ABCD PXA2
CAUR_04133 810 94.1119 ALDP/ABCD PXA1
CAUR_02351 1,106 124.1289 ABCF/YEF3 GCN20
CAUR_03795 1,420 157.7549 ABCF/YEF3 GCN20
CAUR_04953 751 84.7145 ABCF/YEF3 NEW1
CAUR_00824 1,051 116.4815 ABCF/YEF3 GCN20
CAUR_04813 610 68.1726 ABCF/YEF3 HEF3
CAUR_04997 617 68.8987 RLI/ABCE RLI1
CAUR_03076 322 36.9176 OTHERS CAF16
CAUR_04824 547 61.7759 OTHERS CAF16
harbor at least one TMD and one NBD; we consider these
to be localized to membranes (Supplementary Table S5). The
remaining eight proteins lacking a TMD likely are soluble ABC
proteins (Supplementary Table S5).
Phylogenetic Analysis, Domain
Organization, and Subfamily Prediction
of C. auris ABC Proteins
We used the characteristic conserved sequence of NBDs to
classify C. auris ABC proteins into subfamilies. According
to the recent nomenclature suggested by the HUGO gene
nomenclature committee9, eukaryotic ABC superfamily proteins
can be classified into nine subfamilies from ABCA to ABCI (Dean
et al., 2001a). However, not all subfamily members are uniformly
present in all organisms. For instance, the ABCA subfamily does
not exist in yeast, and their presence is limited to plants and
some higher organisms (Kovalchuk and Driessen, 2010). ABCI
is the most recent subfamily added to this classification, whose
existence is confined only to plant taxa (Wasi et al., 2018).
Likewise, members of another subfamily, ABCH, are only found
in insects and zebrafish (Wasi et al., 2018).
9https://www.genenames.org/
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For subfamily predictions, the NBD sequences of putative
ABC proteins of C. auris were extracted using ScanProsite,
and were aligned with the NBD sequences of C. albicans. An
unrooted phylogenetic tree was constructed using the MEGA6.06
software as described in the section “Materials and Methods.”
The well-defined ABC proteins of C. albicans (Gaur et al., 2005)
allowed us to assign the subfamilies of C. auris (Figure 1). The
NBD-based phylogenetic analysis revealed that the ABC proteins
of C. auris clustered into six major subfamilies: (I) pleiotropic
drug resistance (PDR)/ABCG, (II) multidrug resistance
(MDR)/ABCB, (III) MRP/ABCC, (IV) adrenoleukodystrophy
protein (ALDp)/ABCD, (V) RNase-L inhibitor (RLI)/ABCE,
and (VI) elongation factor 3 (YEF3)/ABCF. The proteins not
segregating with any of these subfamilies were categorized as
“Others.” Interestingly, our phylogeny analysis reveals that
within the same subfamily N-terminal and C-terminal NBDs
of all the proteins form separate clusters. This separation of
clusters within a subfamily corroborates previous studies, which
suggested that a common ancestor gives rise to each half of the
proteins within each subfamily, and also may allocate different
functions (Daumke and Knittler, 2001). More recent data also
point to this functional asymmetry between N- and C-terminal
NBDs (Banerjee et al., 2018). Notably, the presence and the
positional order of TMDs and NBDs in each subfamily are
FIGURE 1 | A phylogenetic tree depicting ABC protein subfamilies based on the NBD sequences of C. auris (CBS 10913T) and C. albicans (SC5314). C. auris
(circle) and C. albicans (triangle) ABC protein NBD sequences were aligned using Clustal. The evolutionary relationship was inferred using the neighbor-joining
method, and the evolutionary distances were computed using the Poisson correction method in units of number of amino acid substitutions per site of the MEGA
6.06 package. Reliability of the tree topology was confirmed by bootstrap analysis employing 1,000 replicates. NBD1 represents the N-terminal NBD and NBD2 the
C-terminal NBD.
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specific, and this domain arrangement creates a topological
difference among different members of subfamilies. Thus,
ABC proteins are clustered into three groups. The first group
has a forward topology where the NBD is preceded by the
TMD (TMD-NBD); this is observed in the members of the
ABCC/MRP, ABCB/MDR, and ABCD/ALDp subfamilies. The
second group has a reverse topology where NBD is followed by
TMD (NBD–TMD); this is a typical feature of the ABCG/PDR
subfamily in fungi and plants. A third group of members of
two subfamilies ABCE/RLI and ABCF/YEF3 do not possess any
TMD domain and belong to the soluble ABC proteins.
We utilized the topological distinction to validate our
phylogeny-based subfamily clustering of C. auris ABC
proteins. Using TOPOCONS and TMPRED, the number of
transmembrane helices (TMHs) and their arrangement with
NBDs were identified (Figure 2 and Supplementary Table S5).
Our topology prediction suggests that out of the 20 ABC
proteins possessing a TMD, 6 proteins are half-size transporters
(containing one NBD and one TMD each), while 14 members
can be considered as full transporters because they have 2 TMDs
and 2 NBDs each. A further eight proteins do not have a TMD
and are thus considered soluble ABC proteins (Figure 2 and
Supplementary Table S5).
To get better insight into the evolutionary status of C. auris
ABC proteins, we performed a phylogenetic analysis along with
the full ABC proteins of S. cerevisiae, C. albicans, and D. hansenii
(Figure 3A). Descriptions of each subfamily of C. auris and their
comparative analysis are detailed in the following sections.
ABCG/PDR Subfamily
ABCG/PDR is ubiquitous in eukaryotes and one of the
largest subfamily. Based on combined phylogenetic analysis
and topology predictions, we observed that C. auris harbors
seven ABCG/PDR subfamily members. The number of PDR
members varies among different yeasts. While C. glabrata,
C. albicans, and D. hansenii have higher numbers, the fission
yeast Schizosaccharomyces pombe contains only two PDR genes
(Lamping et al., 2010; Kumari et al., 2018; Wasi et al., 2018).
Our topology analysis confirmed that all PDR subfamily
members of C. auris follow the reverse topology (NBD–TMD)
arrangement. The full transporters contain two NBD–TMD units
following each other (NBD–TMD–NBD–TMD), while half-size
transporters possess only one of each (NBD–TMD) (Lamping
et al., 2010). Out of the seven PDR members, CAUR_02725,
CAUR_02773, CAUR_04233, CAUR_01276, CAUR_01285, and
CAUR_05555 are full transporters, while CAUR_03774 is a
half-size transporter (Figure 2). Each TMD usually possesses
six TMHs; however, in the case of CAUR_02773 protein, its
C-terminal TMD is predicted to consist of eight TMHs; this is
also observed in the PDR-type ABC member DEBHA_Q6BHY3
of D. hansenii (Wasi et al., 2018). Surprisingly, the PDR subfamily
in C. auris has fewer members compared to other yeast species,
such as S. cerevisiae (10 members), C. albicans (9 members),
and D. hansenii (9 members) (Figure 3B). Most PDR subfamily
members of other yeasts are multidrug transporters. However,
only one of the PDR subfamily members (CDR1) of C. auris has
recently been characterized as being directly involved in azole
resistance in C. auris (Kim et al., 2019; Rybak et al., 2019).
The overexpression of PDR transporters correlates well with the
emergence of multidrug resistance in C. albicans, C. glabrata,
and other pathogenic fungi (Prasad and Goffeau, 2012). In
S. cerevisiae, Pdr5 is one of the well-characterized members of this
subfamily. It is capable of extruding a wide range of xenobiotics
and functions as a promiscuous drug transporter (Jungwirth and
Kuchler, 2006; Lamping et al., 2010). C. albicans PDR subfamily
members CDR1 and CDR2 can complement a null mutant of
PDR5 in S. cerevisiae, and importantly are also involved in the
multidrug resistance phenotype of clinical C. albicans isolates
(Prasad et al., 1995; Sanglard et al., 1997). Apart from their
role in drug transport, members of the PDR subfamily have
also shown to impact lipid homeostasis. For instance, Pdr5 in
S. cerevisiae and Cdr1, Cdr2, Cdr3, and Cdr4 of C. albicans are
well-characterized lipid translocators (Prasad et al., 2016).
Based on sequence identity with functionally characterized
members of other yeasts, the functions of C. auris proteins
can be predicted. For instance, CAUR_02725 of C. auris
shows 73 and 68% sequence identity with Cdr1 and Cdr2 of
C. albicans, respectively, thus forming a subgroup. Notably,
our analysis does not reveal an obvious independent homolog
of Cdr2 as in C. albicans and C. glabrata. CAUR_02773
and CAUR_05555 of C. auris show 64% and 68% sequence
identity, respectively, with Cdr4 of C. albicans, and along
with DEBHA_Q6BHY3 and DEBHA_Q6BHY4 of D. hansenii
cluster into a separate subgroup. Interestingly, two proteins,
CAUR_01276 and CAUR_01285, of C. auris cluster together on a
separate branch with Snq2 of C. albicans. However, independent
blast searches show that both the proteins display 60% sequence
identity with Snq2 of C. albicans, which strongly suggests that
C. auris might possess two independent genes coding for Snq2-
like proteins, in contrast to C. albicans and D. hansenii which
only possess a single ortholog. An additional copy of SNQ2
has also been reported in a C. auris isolate belonging to the
S. African geographical clade, B11221 (Muñoz et al., 2018).
A closer examination suggests that these two Snq2-like proteins
form a separate branch from that formed by S. cerevisiae
Snq2 and Pdr18, which perform overlapping functions and
are considered paralogs (Godinho et al., 2018). The separate
blast searches with these two S. cerevisiae proteins show that
C. auris CAUR_01276 and CAUR_01285 have 55 and 54%
sequence identity with Pdr18 and Snq2, respectively. S. cerevisiae
YOL075C of the PDR subfamily and its homologs C. albicans
Cdr6 and D. hansenii DEBHA_B5RUN7 constitute a distinct
cluster, to which CAUR_04233 also belongs; CAUR_04233 has
51% sequence identity with Cdr6. The separation of this cluster
of proteins from other PDR subfamily members suggests an early
origin, as it is among the few ABCG protein members, that
are also observed in primitive eukaryotes like Batrachochytrium
dendrobatidis and Encephalitozoon cuniculi (Kovalchuk and
Driessen, 2010). While YOL075C of S. cerevisiae remains
uncharacterized, its homolog in C. albicans Cdr6 has recently
been shown to impact drug susceptibility mediated by TOR
signaling (Khandelwal et al., 2018).
The only half-size transporter member of the PDR subfamily,
CAUR_03774, harbors a TMH1–NBD–TMH6 topology
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FIGURE 2 | Predicted topology of ABC proteins of C. auris. The domain arrangement of C. auris ABC proteins was generated using my domain builder tool in
PROSITE. The transmembrane helices (TMHs) in transmembrane domain (TMD) were identified with the help of TOPOCONS and nucleotide-binding domain by
ScanProsite. The subfamilies were assigned on the guidelines proposed by Human Genome Organization (HUGO).
(Figure 2), and shows a close phylogenetic relationship
with Adp1 of S. cerevisiae and C. albicans. CAUR_03774 has 54%
sequence identity with S. cerevisiae Adp1, and 67% sequence
identity with C. albicans Adp1. Similar to Adp1, CAUR_03774
is characterized by the presence of a domain containing
epidermal growth factor repeats at its N-terminus, where the first
NBD would be situated, if it were a full-size ABC transporter
(Figure 2). As with D. hansenii and C. albicans, there is no
homolog of S. cerevisiae Aus1 observed in C. auris (Wilcox et al.,
2002). Our subcellular predictions show that similar to the most
closely related PDR subfamily members in S. cerevisiae, most of
the PDR-type ABC proteins in C. auris are probably localized to
the plasma membrane (Supplementary Table S6).
ABCB/MDR Subfamily
The ABCB/MDR subfamily is characterized by a forward
topology, comprising full and half-size transporters. Our analysis
revealed that the MDR subfamily of C. auris has four ABC
transporters: CAUR_01852, CAUR_03761, CAUR_04565, and
CAUR_02994 (Figure 1). Notably, CAUR_03761, CAUR_04565,
and CAUR_02994 are half-size transporters, while CAUR_01852
is predicted to be a full transporter (TMD–NBD–TMD–NBD)
(Figure 2). Unlike the PDR subfamily in C. auris, the number
of MDR subfamily members is equal to S. cerevisiae, C. albicans,
and D. hansenii pointing toward a conserved functional nature
across different fungal species (Figure 3). One of the most
studied examples of this subfamily is human P-glycoprotein,
which is a full transporter, and its overexpression in cancer
cells is associated with multidrug resistance (Ambudkar et al.,
1992). The only full transporter, CAUR_01852, shows close
homology with S. cerevisiae Ste6, which transports pheromones,
and with C. albicans Hst6, which functionally complements Ste6
in S. cerevisiae (Raymond et al., 1998). One of the half-size
transporters, CAUR_02994, displays high sequence identity 77%
and 68% with Atm1 of C. albicans and S. cerevisiae, respectively.
In both species Atm1 is a mitochondrial transporter involved in
exporting Fe–S clusters from the inner mitochondrial membrane
into the cytosol (Leighton and Schatz, 1995). The other two
half-size transporters, CAUR_03761 and CAUR_04565, display
an orthologous relationship with Mdl1 and Mdl2, respectively,
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FIGURE 3 | Continued
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FIGURE 3 | Comparative analysis of C. auris ABC proteins with other yeast. (A) Comparative phylogenetic relationship of C. auris ABC proteins with C. albicans,
D. hansenii, and S. cerevisiae. Symbols: circles represent C. auris proteins, squares D. hansenii proteins, triangles C. albicans proteins, and diamonds S. cerevisiae
proteins. (B) The number of ABC proteins in each subfamily in C. auris, D. hansenii, C. albicans, and S. cerevisiae. Different subfamilies are plotted on the y-axis and
the number of genes is indicated on the x-axis.
which are mitochondrial peptide transporters in S. cerevisiae
(Young et al., 2001; Figure 3A). Our subcellular localization
prediction suggests that CAUR_01852 (the Hst6-homolog) is
localized to plasma membranes, similar to its homolog in
S. cerevisiae (Supplementary Table S6). Notably, the other three
members of MDR family, the Mdl1-homolog CAUR_03761,
the Mdl2-homolog CAUR_04565, and the Atm1-homolog
CAUR_02994, might be present on mitochondrial membranes
(Supplementary Table S6).
ABCC/MRP Subfamily
The ABCC/MRP subfamily is the second largest subfamily of
the ABC superfamily found in most eukaryotes and contains
only full-length transporters. Our analysis showed that C. auris
harbors seven putative MRP subfamily members: CAUR_01188,
CAUR_00156, CAUR_00368, CAUR_00964, CAUR_01719,
CAUR_03320, and CAUR_02951 (Figures 1, 2). Notably, our
comparative analysis reveals that the number of MRP subfamily
members in C. auris (seven members) is equivalent to D. hansenii
(seven members), but expanded compared to C. albicans (four
members) and S. cerevisiae (six members) (Figure 3B).
Multidrug resistance-associated protein subfamily members
form two major clusters: one with CAUR_01188, which aligns
with Ybt1, Vmr1, and Nft1 of S. cerevisiae, and the second major
cluster, which branches into three subgroups (Figures 1, 3A).
Out of these three, one subgroup is formed by the CAUR_00368,
CAUR_01719, and CAUR_02951 of C. auris, and similar to
Yor1 of C. albicans and S. cerevisiae; the second consists of
CAUR_00964 and C. albicans Mlt1; and the third subgroup
contains CAUR_03320 with 67% sequence identity to C. albicans
Ycf1 and CAUR_00156, which displays similarity to S. cerevisiae
Ybt1 and C. albicans Orf19.6382 (Figure 3A).
This subfamily is also known for the presence of long MRP
proteins, which have an extra TMD called the N-terminal
extension (NTE) or (TMD)0. Usually the (TMD)0 consists
of five TMHs and hence long MRPs have a (TMD)0–
(TMD–NBD–TMD–NBD) topology (Figure 2). It is well-
documented in S. cerevisiae that the (TMD)0 of Ycf1 is required
for proper localization to the vacuolar membrane (Mason,
2002). Our analysis shows that out of the seven predicted
members, two members CAUR_01188 and CAUR_03320 possess
a (TMD)0–(TMD–NBD–TMD–NBD) topology and are long
MRPs (Figure 2). Interestingly, another two MRP members,
CAUR_00156 and CAUR_02951, have two additional TMHs
at their N-terminus, displaying an unusual TMH2–(TMH6–
NBD–TMH6–NBD) arrangement (14 TMHs in total) (Figure 2).
However, the phylogenetic analysis clusters CAUR_00156 with
D. hansenii DEBHA_B5RTT1 and C. albicans Orf19.6382,
which are predicted to have 17 TMHs, a (TMD)0–(TMD–
NBD–TMD–NBD) topology (Wasi et al., 2018). CAUR_00368
and CAUR_01719 show a typical (TMD–NBD–TMD–NBD)
topology. Notably, no TMDs are predicted for CAUR_00964
by TOPOCONS software, but it appears to have 12 TMDs and
a (TMD–NBD–TMD–NBD) according to TMPRED software
(Supplementary Table S5).
The members of the MRP subfamily are known to be localized
to vacuoles in various yeasts (Snider et al., 2013; Khandelwal et al.,
2016) and are well known for their roles in cellular detoxification
and sequestration of heavy metal ions in the form of conjugates
with glutathione (GSH), glucuronate, or sulfate (Paumi et al.,
2007). Recently, our group has shown vacuolar localization for
Ybt1 in S. cerevisiae and Mlt1 in C. albicans, which sequester
azoles into the vesicle lumen (Khandelwal et al., 2019). The
MRP transporters are also involved in the translocation of bile
acids and phosphatidylcholine into the vacuole and affect the
regulation of vacuolar fusion (Gulshan and Moye-Rowley, 2011;
Sasser and Fratti, 2014; Khandelwal et al., 2016). The other
member, yeast cadmium factor (Ycf1) of S. cerevisiae helps the
cell with detoxification of heavy metal conjugates with GSH,
vacuolar fusion, and also affects chronological aging (Paumi et al.,
2007; Sasser and Fratti, 2014). Notably, in C. auris out of seven
MRP subfamily members, three transporters (CAUR_00368,
CAUR_01719, and CAUR_02951) lack the extra five TMHs at
the very N-terminus (NTE/TMD0), and hence are predicted to
be localized to the plasma membrane (Supplementary Table S6).
ABCD/ALDp Subfamily
Similar to S. cerevisiae, C. albicans, and D. hansenii, the
ALDp subfamily of C. auris has two members, namely
CAUR_00862 and CAUR_04133 (Figures 1–3). Predominantly,
members of the ALDp subfamily are half-size transporters
with a forward topology (TMD–NBD); in plants also full-
length transporters of this subfamily have been described
(Wasi et al., 2018). The half-size ALDp transporters turn
into functionally complete transporters after hetero- or homo-
dimerization (Morita and Imanaka, 2012).
The members of the ALDp subfamily are also known as
the peroxisomal ABC transporters, which are involved in fatty
acid regulation (Morita and Imanaka, 2012). Our localization
predictions suggest that C. auris members of this subfamily
are also peroxisomal transporters (Supplementary Table S6).
Phylogenetic analysis indicates that CAUR_04133 is homologous
to Pxa1 (44% identity), while CAUR_00862 is 42% identical with
Pxa2 of S. cerevisiae (Figure 3A). Pxa1 and Pxa2 are long chain
fatty acid transporters in S. cerevisiae (van Roermund et al.,
2012). The clear evolutionary orthologous relationship between
the ALDp subfamily members in various species strongly points
toward conserved functions.
ABCE/RLI Subfamily
This subfamily belongs to the soluble ABC proteins as its
members are devoid of TMD regions and have only two NBDs in
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tandem (NBD–NBD) (Figure 2). ABCE-subfamily proteins are
also known as RLIs because of their ability to inhibit the double-
stranded RNA nuclease RNase L. However, these proteins are
also present in organisms, which do not have RNase L implying
their involvement in other important cellular functions (Wasi
et al., 2018). The RLI subfamily has the lowest member count
among all ABC proteins (Figure 3B). Indeed, C. auris contains
a single member, CAUR_04997, belonging to this subfamily.
The main distinctive feature of RLI subfamily proteins is the
presence of a conserved ferredoxin iron–sulfur cluster (4Fe4S-
type) (CX2CX2CX3C) motif (Gaur et al., 2005). RLI-subfamily
proteins are implicated in processes such as ribosome biogenesis
and translation initiation at the 3′-untranslated region of ORFs
(Wasi et al., 2018).
ABCF/YEF3 Subfamily
Similar to RLI-type ABC proteins, ABCF/YEF3 subfamily
members characteristically have two NBDs (NBD–NBD) and
no TMDs (Figure 2), and are also considered soluble ABC
proteins. In C. auris, this subfamily has five protein members:
CAUR_04813, CAUR_02351, CAUR_03795, CAUR_04953, and
CAUR_00824. The combined phylogenetic analyses showed that
CAUR_00824 forms a tight cluster with C. albicans Cef3 and
D. hansenii DEBHA_Q6BK70, and a wider cluster with its
ortholog in S. cerevisiae, Yef3 and Hef3 (Figure 3A). It is worth
pointing out that except for S. cerevisiae with two YEF3-like
proteins, most fungi have only a single YEF3 ortholog (Kovalchuk
and Driessen, 2010). Yef3 in S. cerevisiae is involved in translation
elongation by supporting the binding of aminoacyl-tRNA to the
ribosome. CAUR_04953 of C. auris shows high sequence identity
with S. cerevisiae Gcn20 (72%) and with C. albicans Gcn20
(87%). Gcn20 is one of the most-studied members of the YEF3
subfamily, and it is involved in amino acid biosynthesis through
the positive regulation of Gcn2 kinase activity (Yuan et al., 2017).
Similar to the other CTG-clade yeasts C. albicans and D. hansenii,
no Arb1-like protein can be detected in C. auris (Figure 3A).
Arb1 is majorly responsible for maintaining ribosome biogenesis
in S. cerevisiae (Dong et al., 2005).
Others: Unclassified ABC Proteins
This group of ABC proteins comprises members that remain
separated from the main subfamilies. It contains soluble ABC
proteins, because of the absence of TMDs within their sequences.
Our analysis shows that C. auris has two proteins in this
group, namely CAUR_3076 and CAUR_04824 (Figure 1).
Topology predictions show that CAUR_04824 has NBD-NBD
architecture, while CAUR_3076 harbors a single NBD (Figure 2).
The phylogenetics points to a close relationship between
CAUR_04824 and Modf of C. albicans with a sequence identity of
50%, while CAUR_3076 seems orthologous to S. cerevisiae Caf16,
which is part of the CCR4–NOT complex and has a regulatory
role in transcription (Liu et al., 2011).
Expression Analysis Confirms Putative
ABC Transporter Genes Transcripts
As a goal of evaluating the role of ABC proteins as drug
transporters in C. auris (CBS 10913T), we first assessed the
basal expression of all 20 genes encoding membrane-bound
ABC proteins. The basal expression profile of all the putative
ABC transporter genes was quantified and normalized in
comparison to TDH1 (CAUR_02457) gene expression. TDH1
is a housekeeping gene, which is an ortholog of GAPDH, a
housekeeping gene commonly used as internal control for qRT-
PCR (Kumari et al., 2018). The expression profile of the CBS
10913T strain established the presence of transcripts of all the
20 predicted putative ABC transporter genes, and highlighted
a variability of basal expression between them (Figure 4).
Although all the ABC transporters showed lower expression
than housekeeping gene GAPDH, ABC transporters do show
constitutive differential expression, which suggests possible
different roles. The C. albicans CDR1-ortholog CAUR_02725
showed the highest level of basal expression. CAUR_01852 (the
homolog of STE6/HST6) showed the least basal expression
among the 20 ABC transporter genes. Notably, similar low
expression of C. glabrata CAGL0K00363g, an ortholog of
S. cerevisiae STE6 has been reported (Kumari et al., 2018). SNQ2
orthologs, CAUR_01276 and CAUR_01285, showed similar levels
of basal expression. Notably, CAUR_01852 lacks two nucleotides
at positions 3,309 and 3,310 in clade I strains B8441, 6684,
and VPCI 479/P/13, and could be considered a pseudogene in
these. However, in isolates from all other clades, CBS 10913T,
B11220, B11221, and B11243, these residues are present and the
ORFs seem to be intact. Considering this and that CAUR_01852
is transcribed, albeit at low levels, raises the possibility that
FIGURE 4 | Basal expression levels of ABC transporter genes in C auris
CBS10913T. The presence of true ABC transporters ORFs was confirmed
using qRT-PCR. Expression levels were calculated using the 2−1CT methods
with the house-keeping TDH1 gene as internal control. Here 2−1CT
represents the relative expression of ABC transporter in comparison to TDH1
gene and its value 1 meaning that the gene expressing equal to the internal
control TDH1. The values are means ± SE (error bars) from triplicates of
biological duplicates (n = 6).
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CAUR_01852 is functional in C. auris isolates from clades
II, III, and IV.
ABC Transporters Display Selective
Response to Drug Treatment
To assess the role of ABC transporters in drug resistance,
we examined the changes in ABC transporter transcript levels
in response to short-term drug exposure by qRT-PCR. For
this, we treated C. auris CBS 10913T with different classes of
known antifungals, specifically the polyene AMPB, the allylamine
TRB, and the triazole FLU. The following MIC50 values were
used for each drug in YEPD broth for 60 min treatments
of the C. auris CBS 10913T strain: AMPB at 0.7 µg/ml,
TRB at 0.75 µg/ml, and FLU at 6 µg/ml (Supplementary
Table S2). The qRT-PCR analysis was performed after the drug
treatment and compared with untreated cells (Figure 5). The
transcripts of subfamily members were differentially regulated
in the presence of the antifungals (Figure 5). PDR subfamily
members are well-known drug transporters implicated in clinical
drug resistance encountered in different fungi. The observed
upregulation of PDR subfamily members of C. auris strongly
highlights a potential role in drug resistance. Among all the
three drugs, AMPB exposure presented maximum response in
terms of upregulated expression of selected ABC transporter
genes. Particularly, the PDR subfamily genes exhibited higher
expression after AMPB exposure, including CAUR_05555 (one
of the homologs of CDR4), CAUR_04233 (homolog of CDR6),
and both homologs of SNQ2: CAUR_01285 and CAUR_01276
(Figure 5). An elevated expression of the SNQ2 homologs in
C. glabrata and S. cerevisiae has also been observed after AMPB
treatment (Rogers et al., 2001); this indicates that CAUR_01285
and CAUR_01276 could be involved in drug susceptibility in
C. auris as well. Incidentally, the more than eightfold higher
expression of the CDR6-homolog CAUR_04233 was highest
among all ABC transporter transcripts (Figure 5). Interestingly,
CAUR_04233 was also strongly upregulated among transcripts
following TRB treatment (Figure 5).
In our present study, ABC genes show maximum
transcriptional response to AMPB treatment. This observation
also matches the situation in S. cerevisiae, in that transcriptional
changes in transporters is a major category (10.3% of total genes)
FIGURE 5 | Drug induced expression profiles of various ABC transporter genes in C. auris. The expression levels of different genes were checked by qRT-PCR and
data were measured by 2−11CT method in the presence of amphotericin B (0.7 µg/ml), terbinafine (0.75 µg/ml), and fluconazole (6 µg/ml) in comparison to sample
with no drug treatment. TDH1 was used as an internal control. The dotted lines represent the selected biological significant cut off (more than or equal to twofold).
2−11CT represents the fold change and its values 2, 1, and 0.5 represent twofold up, no change, and twofold down regulation, respectively. Data presented as
means ± SE (error bars) from biological replicates with technical triplicates (n = 6). P-values (∗p ≤ 0.05, ∗∗p ≤ 0.001, ∗∗∗p ≤ 0.0001, and ∗∗∗∗p ≤ 0.00001) were
calculated with two-way ANOVA (uncorrected Fisher’s LSD) using GraphPad prism. P-values are for differences from the fold change of 1.
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affected by AMPB treatment (Zhang, 2002; Agarwal et al., 2003).
Also, in D. hansenii AMPB treatment resulted in a significant
increase in the expression of several ABC transporters (Wasi
et al., 2018). This suggests that AMPB treatment-dependent
change in expression of ABC transporters is a common response
observed in various yeasts.
Considering the well-established role of ABC transporters in
membrane lipid homeostasis and the fact that the expression level
of ABC transporters can impact AMPB sensitivity, the commonly
observed up-regulation of ABC transporters could be a crucial
defense mechanism (Smriti et al., 2002; Rockwell et al., 2009;
Guan et al., 2010; Nagi et al., 2013; Gulati et al., 2015). The TOR1
pathway also governs AMPB persistence in yeast (Bojsen et al.,
2016), indeed, we have recently shown that the ABC transporter
Cdr6 can impact TOR signaling and its absence induces the
TOR signaling cascade (Khandelwal et al., 2018). This suggests
that ABC transporters and TOR signaling are linked and over-
expression of ABC transporters could also impact the AMPB
sensitivity via TOR signaling.
Strikingly, unlike AMPB and TRB exposure, none of the
ABC transporter transcripts showed any significant changes in
their expression following FLU treatment (Figure 5). A similar
observation was recently reported by Cuomo and co-workers,
where they show a lack of response after VRC treatment
(Muñoz et al., 2018).
PDR Subfamily Genes Predominantly
Display Elevated Transcript Levels in
Drug-Resistant Clinical Isolates of
C. auris
The upregulated expression of certain ABC transporters
correlates well with an increased resistance to antifungals in
clinical isolates of C. albicans, C. glabrata, and other pathogenic
fungi (Sanglard et al., 1999). The upregulation of ABC transporter
genes associated with rapid expulsion of antifungal drugs is
one of the major strategies adapted by clinical multidrug-
resistant strains. To evaluate the relevance of ABC transporter
expression levels in multidrug-resistant C. auris, we evaluated
their expression in three selected clinical isolates of C. auris in
comparison to C. auris (CBS 10913T). These were resistant to
AMPB and FLU, and also displayed elevated MIC50s to VRC and
ITR (Table 2).
The transcript analysis confirmed the involvement of
PDR subfamily members in drug resistance of the emerging
TABLE 2 | In vitro susceptibility profile (MIC50 values in RPMI media) of C. auris
strains used in the study to antifungal drugs.
Strain AMPB FLU VRC ITR
C. auris CBS 10913T 1 1 0.03 0.12
Isolate-1 1 > 64 1.00 0.25
Isolate-2 1 > 64 0.50 0.13
Isolate-3 4 64 1.00 0.25
MIC values are given in µg/ml. AMPB, amphotericin B; FLU, fluconazole; VRC,
voriconazole; ITR, itraconazole.
pathogenic C. auris. Accordingly, the CDR1-homolog
CAUR_02725 and the SNQ2-homolog CAUR_01276 displayed
higher transcript levels in all tested clinical isolates suggesting
a role as a drug exporter in C. auris (Figure 6). A role in
multidrug resistance including resistance to azoles is well-
established for Cdr1 in C. albicans and Snq2 in C. glabrata
(Whaley et al., 2018).
Another PDR subfamily member, CAUR_04233 (CDR6
homolog), is (more than or equal to twofold) upregulated in
Isolate-1. It also showed a trend toward higher expression in
Isolate-2 and Isolate-3, but it was not considered significant
since it was below our selected threshold (more than or
equal to twofold) of upregulation (Figure 6A). In C. albicans
the Cdr6 transporter is known as an exporter of xenobiotics
(Khandelwal et al., 2018). One of the homologs of CDR4
(CAUR_05555) is upregulated in clinical Isolate-1 and Isolate-
3 (Figure 6A), interestingly, elevated expression of CDR4 in
clinical multidrug-resistant C. albicans and C. glabrata strains has
not been reported.
Among the MDR subfamily members, the homolog of STE6
(CAUR_001852) was the only member that exhibited elevated
expression in Isolate-1 and Isolate-2 (Figure 6A). Notably, Ste6 is
not an established drug transporter, but a dedicated pheromone
transporter in S. cerevisiae (Kumari et al., 2018). However, one
study has reported that Ste6 could also impart resistance to
valinomycin in S. pombe (Christensen et al., 1997). In C. glabrata,
the transcripts of a STE6 homolog (CAGL0K00363g) displayed
variable response to drug exposure (Kumari et al., 2018), and
also, the human Ste6 homolog, ABCB1, has been shown to
extrude xenobiotics in various chemotherapy-resistant tumors
(He et al., 2011). Notably, none of the MDR transporters
showed more than or equal to twofold downregulation. However,
CAUR_02994 (ATM1 homolog) of the MDR subfamily showed
1.8- and 1.7-fold downregulation in Isolate-1 and Isolate-2,
respectively (Figure 6A). This is in contrast to what was
observed after transient exposure of C. auris CBS 10913T to
AMPB where a more than twofold increase in CAUR_02994
expression was observed. The homolog of ATM1 in C. glabrata
(CAGL0M13739g) displayed raised expression levels following
ketoconazole treatment (Kumari et al., 2018).
Recent studies established the roles of MRP subfamily
members in fungal drug resistance and virulence (Gulshan
and Moye-Rowley, 2011; Khandelwal et al., 2016, 2019). We
observed that CAUR_00368, which displays close identity with
YOR1, is upregulated in all three clinical isolates (Figure 6B). In
C. albicans, Yor1 is involved in expulsion of beauvericin, a natural
antimicrobial (Shekhar-Guturja et al., 2016). Upregulation of
YOR1 transcription in C. auris indicates a potential role
in multidrug resistance of this pathogen. CAUR_01188/YBT1,
CAUR_00156/BPT1, and CAUR_03320/YCF1 show upregulation
in two isolates (Isolate-1 and -3). These three transporters
are known to be involved extruding various xenobiotics in
S. cerevisiae (Paumi et al., 2007).
The ALDp subfamily member CAUR_04133/PXA1 transcript
is significantly (more than or equal to twofold) down regulated in
clinical Isolate-3 (Figure 6B). In clinical Isolate-1, the expression
of CAUR_04133 is also decreased (1.93-fold) compared to WT
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FIGURE 6 | Expression levels of ABC transporter genes in drug-resistant clinical isolates of C. auris. (A) The expression levels of the various ABC transporter genes
in three clinical isolates in comparison to the reference strain CBS 10913T was checked by qRT-PCR. Fold change (2−11CT) measured and presented as
means ± SE (error bars) (n = 3). TDH1 was used as an internal control. The dotted lines represent the selected biological significant cut off (more than or equal to
twofold). P-values (∗p ≤ 0.05, ∗∗p ≤ 0.001, ∗∗∗p ≤ 0.0001, and ∗∗∗∗p ≤ 0.00001) were calculated with two-way ANOVA (uncorrected Fisher’s LSD) using
GraphPad prism. P-values are for differences from the fold change of 1. (B) Interaction map of ABC transporters in the clinical isolates was made by taking the
arbitrary cut off of (more than or equal to twofold) change with the help of Cytoscape software version 3.4.0 (Shannon et al., 2003).
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(CBS10913T) (Figure 6A). Coincidently, in C. glabrata its
homolog CAGL0M02387 is also downregulated when treated
with ketoconazole (Kumari et al., 2018).
CONCLUSION
The increasing reports of C. auris outbreaks and its emerging
resistance to common antifungal pose an alarming clinical
situation for hospitals. An established role of ABC transporters
in multidrug resistance of different fungal pathogens highlights
an essential requirement for understanding the impact these
ABC proteins might have in C. auris. Here, we have analyzed
the full repertoire of ABC proteins of the C. auris type
strain CBS 10913T.
During the preparation of this manuscript two studies were
published (Kim et al., 2019; Rybak et al., 2019) which further
highlighted the role of some of the ABC transporters (mainly of
PDR family) of C. auris. Our study is a comprehensive analysis
of total landscape of ABC protein in C. auris. Our evaluation
identified 28 putative ABC proteins, which is based on phylogeny
and domain organization, demonstrated that these could be
clustered into the six major ABC transporter subfamilies. Of
these, 20 of the putative ABC proteins contain TMDs and are
categorized into the four membrane-localized subfamilies. The
constitutive expression of these membrane-localized transporters
confirmed their presence as true ORFs, while differential
expression of the genes encoding ABC transporters implies
different biological and clinical relevance. The selective responses
of some of these transporters to antifungal drug treatment
possibly provide a clue of their relevance in clinically drug
resistance mechanisms. The higher expression (more than or
equal to twofold) of the CAUR_02725 (CDR1) and CAUR_01276
(SNQ2) ABC transporters in multidrug-resistance clinical isolates
of C. auris also supports that these transporters may be involved
in drug resistance. Our study therefore provides the first complete
landscape of ABC transporters of this pathogen, which presents
a pivotal platform for further exploration of this important
class of proteins and their relevance in multidrug resistance
in C. auris.
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